547 related articles for article (PubMed ID: 17576407)
1. Fungal infections in neonates: update on prevention and treatment.
Kaufman DA
Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
[TBL] [Abstract][Full Text] [Related]
3. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants.
Aziz M; Patel AL; Losavio J; Iyengar A; Berven M; Schloemer N; Jakubowicz A; Mathai T; McAuley JB
Pediatr Infect Dis J; 2010 Apr; 29(4):352-6. PubMed ID: 19934791
[TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of invasive fungal infection in very low birthweight infants.
Brecht M; Clerihew L; McGuire W
Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F65-9. PubMed ID: 18838467
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of Candida infections in neonates.
Chapman RL
Semin Perinatol; 2007 Feb; 31(1):39-46. PubMed ID: 17317426
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
Healy CM; Campbell JR; Zaccaria E; Baker CJ
Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
[TBL] [Abstract][Full Text] [Related]
9. Combined antifungal therapy in a murine infection by Candida glabrata.
Mariné M; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
[TBL] [Abstract][Full Text] [Related]
10. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
11. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
[TBL] [Abstract][Full Text] [Related]
12. [Fungal infections in children with malignant disease].
Michel G
Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
[TBL] [Abstract][Full Text] [Related]
13. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?
Kaufman DA
Curr Opin Pediatr; 2008 Jun; 20(3):332-40. PubMed ID: 18475105
[TBL] [Abstract][Full Text] [Related]
15. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
16. Systemic fungal infections in neonates.
Rao S; Ali U
J Postgrad Med; 2005; 51 Suppl 1():S27-9. PubMed ID: 16519252
[TBL] [Abstract][Full Text] [Related]
17. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
[TBL] [Abstract][Full Text] [Related]
18. Antifungal treatment in patients with cancer.
Viscoli C; Castagnola E; Machetti M
J Intern Med Suppl; 1997; 740():89-94. PubMed ID: 9350188
[TBL] [Abstract][Full Text] [Related]
19. Combination antifungal therapy: where are we now, and where are we going?
Marr K
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):24-9. PubMed ID: 15651179
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
